Fig. 1From: Osteoporosis clinical practice guideline: romosozumab for treating severe osteoporosis – an update by the Egyptian Academy of Bone HealthPre-romosozumab, patient self-reported questionnaire to screen for possible risks. It also include the baseline bone health status as assessed by the treating healthcare professionalBack to article page